Health care for workers

On this Labor Day, how is healthcare evolving for workers and firms? First, healthcare spending is on the rise, with costs increasing more than inflation. Fox Business reports on a new Aon study which says that: …employer health care expenditures are projected to surge 9% in 2025 to more than $16,000 per employee, markedly higher…

Read More

“Moral Distress” Has Arrived On Health Care’s Stoop

By MIKE MAGEE When Andrew Jameton, a Nursing Professor at the Department of Mental Health and Community Nursing at UCSF in 1984 published “Nursing Practice: The Ethical Issues”, the term “Moral Distress” was a novel term in clinical health care. It focused primarily on “care that they were expected to provide but ethically opposed.” Over…

Read More

Links

How do companies decide which drugs to develop?“attending a more selective college causally reduces obesity”28% of patients with HIV were covered by MedicareThe AI Scientist + End-to-end causal effect estimation Development approval timelines and new housing supply in LA

Read More

Value Assessment Approaches for Duchenne Muscular Dystrophy Therapies

Check out my new paper titled “Healthcare Stakeholder Perspectives on a Value Assessment Approach for Duchenne Muscular Dystrophy Therapies“. The abstract is below. Purpose: Traditional value assessment frameworks are challenged in comprehensively assessing the societal value new therapies bring to individuals with rare, progressive, genetic, fatal, neuromuscular diseases such as Duchenne muscular dystrophy (DMD). The…

Read More

Can appointment-based models (ABM) reduce total cost of care?

Managing multiple medications is a challenge for many individuals, particularly the elderly. One study by Almodóvar et al. (2019) found that among Medicare beneficiaries eligible for medication therapy management (MTM), 51% had used 11 or more medications. One approach to improving medication management is to use an appointment-based model (ABM) and other forms of medication…

Read More

Biology to the Rescue?

By KIM BELLARD I feel much about synthetic biology as I do AI: I don’t really understand it from a technical point of view, but I sure am excited about its potential. Sometimes they even overlap, as I’ll discuss later. But I’ll start with some recent developments with bioplastics, a topic I have somehow never…

Read More